91 related articles for article (PubMed ID: 25641893)
1. Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort study.
Yamazaki H; Sakai R; Koike R; Miyazaki Y; Tanaka M; Nanki T; Watanabe K; Yasuda S; Kurita T; Kaneko Y; Tanaka Y; Nishioka Y; Takasaki Y; Nagasaka K; Nagasawa H; Tohma S; Dohi M; Sugihara T; Sugiyama H; Kawaguchi Y; Inase N; Ochi S; Hagiyama H; Kohsaka H; Miyasaka N; Harigai M;
J Rheumatol; 2015 Apr; 42(4):614-22. PubMed ID: 25641893
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.
Tanaka M; Koike R; Sakai R; Saito K; Hirata S; Nagasawa H; Kameda H; Hara M; Kawaguchi Y; Tohma S; Takasaki Y; Dohi M; Nishioka Y; Yasuda S; Miyazaki Y; Kaneko Y; Nanki T; Watanabe K; Yamazaki H; Miyasaka N; Harigai M
Mod Rheumatol; 2015 Jul; 25(4):609-14. PubMed ID: 25496409
[TBL] [Abstract][Full Text] [Related]
3. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
[TBL] [Abstract][Full Text] [Related]
4. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy.
Glück T; Kiefmann B; Grohmann M; Falk W; Straub RH; Schölmerich J
J Rheumatol; 2005 Aug; 32(8):1473-80. PubMed ID: 16078322
[TBL] [Abstract][Full Text] [Related]
5. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.
Godeau B; Coutant-Perronne V; Le Thi Huong D; Guillevin L; Magadur G; De Bandt M; Dellion S; Rossert J; Rostoker G; Piette JC
J Rheumatol; 1994 Feb; 21(2):246-51. PubMed ID: 8182632
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis carinii pneumonia in patients with connective tissue disease.
Li J; Huang XM; Fang WG; Zeng XJ
J Clin Rheumatol; 2006 Jun; 12(3):114-7. PubMed ID: 16755237
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy.
Mori T; Kameda H; Ogawa H; Iizuka A; Sekiguchi N; Takei H; Nagasawa H; Tokuhira M; Tanaka T; Saito Y; Amano K; Abe T; Takeuchi T
J Rheumatol; 2004 Jul; 31(7):1349-51. PubMed ID: 15229955
[TBL] [Abstract][Full Text] [Related]
9. Durability of thoracoabdominal aortic aneurysm repair in patients with connective tissue disorders.
Dardik A; Krosnick T; Perler BA; Roseborough GS; Williams GM
J Vasc Surg; 2002 Oct; 36(4):696-703. PubMed ID: 12368728
[TBL] [Abstract][Full Text] [Related]
10. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
11. Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.
Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Langholff W; Londhe A; Sandborn WJ
Am J Gastroenterol; 2014 Feb; 109(2):212-23. PubMed ID: 24394749
[TBL] [Abstract][Full Text] [Related]
12. Survival analysis and risk factors for mortality in connective tissue disease-associated pneumomediastinum.
Zhang L; Shen M; Zhang F; Tang F
Rheumatol Int; 2014 Dec; 34(12):1657-63. PubMed ID: 24871160
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
Michel M; Habibi A; Godeau B; Bachir D; Lahary A; Galacteros F; Fifi-Mah A; Arfi S
Semin Arthritis Rheum; 2008 Dec; 38(3):228-40. PubMed ID: 18177923
[TBL] [Abstract][Full Text] [Related]
14. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
[TBL] [Abstract][Full Text] [Related]
15. Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy.
Keir GJ; Maher TM; Hansell DM; Denton CP; Ong VH; Singh S; Wells AU; Renzoni EA
Eur Respir J; 2012 Sep; 40(3):641-8. PubMed ID: 22282550
[TBL] [Abstract][Full Text] [Related]
16. Severe infections in patients with autoimmune diseases treated with cyclophosphamide.
Cavallasca JA; Costa CA; Maliandi Mdel R; Contini LE; Fernandez de Carrera E; Musuruana JL
Reumatol Clin; 2015; 11(4):221-3. PubMed ID: 25455720
[TBL] [Abstract][Full Text] [Related]
17. Survival and extrapulmonary course of connective tissue disease after lung transplantation.
Takagishi T; Ostrowski R; Alex C; Rychlik K; Pelletiere K; Tehrani R
J Clin Rheumatol; 2012 Sep; 18(6):283-9. PubMed ID: 22955476
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
19. Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications.
Gerhart JL; Kalaaji AN
J Am Acad Dermatol; 2010 Jun; 62(6):957-61. PubMed ID: 19828210
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
